The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
PAAB Forum Quarterly Review - Q4/2023
-
Happy New Year @Manufacturer @Agency
As we kick off 2024, let's recap a highly active Q4 in 2023 to make sure you didn't miss anything. You'll now find the PAAB Forum Quarterly Review Q4 posted to the PAAB website.
As always, please share your thoughts and comments below.
We're looking forward another year of growth and collaboration.
